graph Evidence gap map comparisons
atezolizumab based treatmentnivolumab based treatment
atezolizumab plus cometinib nivolumab alone
mML - L1 - BRAF wild 3     
Comparator:  vs pembrolizumab alone;   vs dacarbazine; 
Risk of bias:  low;   some concerns;   high;  NA;